5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2024

Diabetes Care, Journal Year: 2023, Volume and Issue: 47(Supplement_1), P. S77 - S110

Published: Dec. 11, 2023

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide components diabetes care, general treatment goals guidelines, tools evaluate quality care. Members ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating Standards annually, or more frequently as warranted. For a detailed description standards, statements, reports, well evidence-grading system full list Committee members, please refer Introduction Methodology. Readers who wish comment on invited do so at professional.diabetes.org/SOC.

Language: Английский

---

ISPAD Clinical Practice Consensus Guidelines 2022: Nutritional management in children and adolescents with diabetes

Pediatric Diabetes, Journal Year: 2022, Volume and Issue: 23(8), P. 1297 - 1321

Published: Dec. 1, 2022

The author declares that there is no conflict of interest. peer review history for this article available at https://publons.com/publon/10.1111/pedi.13429. There original data linked to guideline.

Language: Английский

---

5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2025

Diabetes Care, Journal Year: 2024, Volume and Issue: 48(Supplement_1), P. S86 - S127

Published: Dec. 9, 2024

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide components diabetes care, general treatment goals guidelines, tools evaluate quality care. Members ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating Standards annually, or more frequently as warranted. For a detailed description standards, statements, reports, well evidence-grading system full list Committee members, please refer Introduction Methodology. Readers who wish comment on invited do so at professional.diabetes.org/SOC.

Language: Английский

---

Seven decades of Ramadan intermittent fasting research: Bibliometrics analysis, global trends, and future directions

Diabetes & Metabolic Syndrome Clinical Research & Reviews, Journal Year: 2022, Volume and Issue: 16(8), P. 102566 - 102566

Published: July 8, 2022

Language: Английский

---

First‐Time Usage of SGLT2 Inhibitors in Patients With Type 2 Diabetes Who Are Fasting Ramadan: Efficacy and Safety

Journal of Diabetes Research, Journal Year: 2025, Volume and Issue: 2025(1)

Published: Jan. 1, 2025

Introduction: Ramadan fasting claims a necessary role in the management of diabetes. Many people with Type 2 diabetes insist on during holy month Ramadan, which represents challenge to their physicians provide balance between preventing hypoglycemia or diabetic ketoacidosis (DKA) and good control hyperglycemia its short- long-term complications. Sodium-glucose cotransporter inhibitors (SGLT2is) are glucose-lowering therapy for diabetes, generally well tolerable but may carry risk dehydration particularly long hours. The study aimed assess efficacy safety use SGLT2i first time fasting. Methods: This prospective cohort was carried out 61 Egyptian Muslim patients, aged ≥ 18 years old, both sexes, mellitus (T2DM), prepared fast treated as supplementary metformin another oral hypoglycemic drug. dose started after Iftar time. During 6 weeks evaluations were conducted. Results: Glycated hemoglobin (HbA1c), blood pressure (systolic diastolic), creatinine significantly lower than at beginning Ramadan. estimated glomerular filtration rate (eGFR) higher Hypoglycemia, dehydration, DKA did not occur any patient. There significant negative correlation age HbA1c (r = -0.267, 95% CI: -0.48 -0.05; p 0.037) eGFR -0.684, -0.79 -0.54; < 0.001) while there no duration DM before patients ischemic heart disease (IHD), hypertension (HTN), peripheral neuropathy (PN), chronic kidney (CKD) (p 0.05). Conclusions: is effective safe reduction HBA1c, pressure, elevation eGFR. Trial Registration: ClinicalTrials.gov identifier: NCT06370247.

Language: Английский

---

A Real-World Prospective Study of the Effectiveness and Safety of Automated Insulin Delivery Compared With Other Modalities of Type 1 Diabetes Treatment During Ramadan Intermittent Fasting

Diabetes Care, Journal Year: 2024, Volume and Issue: 47(4), P. 683 - 691

Published: Jan. 30, 2024

OBJECTIVE To compare the fasting experience and glycemic control during Ramadan among people with type 1 diabetes (PWT1D) who use automated insulin delivery (AID) versus other modalities of treatment. RESEARCH DESIGN AND METHODS A total 294 PWT1D attempted in 2022 were categorized on basis treatment modality into one five groups: 1) AID (n = 62); 2) conventional pump + continuous glucose monitoring (CGM; n 37); 3) self-monitoring blood (SMBG; 8); 4) multiple daily injections (MDI) CGM 155); 5) MDI SMBG 32). Predictors most days (i.e., breaking fast ≤2 because diabetes) analyzed using uni- multivariable logistic regression. RESULTS The median numbers when was broken 2, 5, 3, 3.5, 2.5 for AID, CGM, SMBG, users, respectively (P 0.047). Users had a significantly greater time range (TIR) lower glycemia risk index, below range, above compared users pumps (both P &lt; 0.05). Likewise, 53% attained double target maintaining TIR ≥70% only 3% 44% Compared twice as likely to complete Ramadan. CONCLUSIONS Use is associated highest rates best fasting.

Language: Английский

---

Religious fasting and its impacts on individual, public, and planetary health: Fasting as a “religious health asset” for a healthier, more equitable, and sustainable society

Frontiers in Nutrition, Journal Year: 2022, Volume and Issue: 9

Published: Nov. 24, 2022

Religious fasting is practiced by people of all faiths, including Christianity, Islam, Buddhism, Jainism, as well Hinduism, Judaism, and Taoism. Individual/clinical, public, global, planetary health has traditionally been studied separate entities. Nevertheless, religious fasting, in conjunction with other assets, can provide several opportunities, ranging from the individual to population, environmental, levels, facilitating supporting societal transformations changes, such adoption healthier, more equitable, sustainable lifestyles, therein preserving Earth's systems addressing major interconnected, cascading, compound challenges. In this review, we will summarize most recent evidence on effects particularly Orthodox Ramadan Islamic human public health. Further, explore potential tackling current environmental issues, a special focus nutrition/food restriction Finally, specific recommendations, around dietary intake during rituals, be provided ensure healthy planet.

Language: Английский

---

Validity of the International Diabetes Federation risk stratification score of Ramadan fasting in individuals with diabetes mellitus

Saudi Medical Journal, Journal Year: 2024, Volume and Issue: 45(1), P. 86 - 92

Published: Jan. 1, 2024

Objectives:

To assess the validity of new International Diabetes Federation-Diabetes and Ramadan Alliance (IDF-DAR) risk stratification tool for fasting in predicting diabetic patients’ ability to fast safely.

Methods:

A prospective observational study was carried out during 2022 at Center, King Fahad Hospital, Al-Madinah Al-Munawarah, Saudi Arabia. The IDF-DAR used calculate patients pre-Ramadan. were allocated into 3 categories: high, moderate, low risk. Fasting left up their healthcare providers. Participants filled a log-sheet each day showing whether they completed fast. final interview after experiences.

Results:

We included 466 with diabetes: 79.4% T2DM 20.6% T1DM. Based on score, 265 (56.9%) classified as high risk, 115 (24.7%) moderate 86 (18.4%) Non-fasting whole month statistically relevant score. High-risk individuals more likely experience hypoglycemia hyperglycemia than those or But overall, 70.4% people 53.2% ones observed Ramadan’s complete

Conclusion:

has proven be reliable valid adverse events associated patients. Nonetheless, it might overestimate some

Language: Английский

---

Effect of physical activity promotion program on adherence to physical exercise among patients with type II diabetes in North Shoa Zone Amhara region: a quasi-experimental study

BMC Public Health, Journal Year: 2023, Volume and Issue: 23(1)

Published: April 19, 2023

Abstract Background Diabetes is a significant global public health issue that necessitates self-management. However, this difficult to put into practice and requires new approach. The purpose of study was assess the effects physical activity promotion program on adherence recommended lessons improve Methods A quasi-experimental conducted from January 2020 February 2021 at North Shoa Zone Public Hospital. enrolled 216 type II diabetic patients four hospitals. Data were entered Epi V.3.1 analyzed using SPSS version 22. presented as means standard deviations for continuous variables percentages categorical variables. Intervention control groups compared before after intervention independent t-tests. p-value less than 0.05 considered all statistical tests. Results total diabetics participated in study. Physical programs increased number days duration (spending time) (p < 0.0001). Participants who engaged significantly mean scores exercising moderate-intensity activities spending time 0.05), walking least 10 min continuously recreational 0.05).There reduction fasting blood glucose participating 0.05). Conclusion This demonstrates makes difference patient compliance with effectively improves glycemic control. Health care providers should integrate existing systems common therapeutic service. Primary platforms such posts centers can play key role integrating self-management behaviors.

Language: Английский

---

The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan

Diabetes Obesity and Metabolism, Journal Year: 2023, Volume and Issue: 26(3), P. 937 - 949

Published: Dec. 27, 2023

Abstract Aim To report on the effectiveness and safety of MiniMed 780G automated insulin delivery system in real‐world users during month Ramadan. Materials Methods CareLink Personal data were extracted from Gulf region. Users included if they had ≥10 days sensor glucose Ramadan 2022 as well before after. For main analysis, continuous monitoring endpoints aggregated per reported by time day (daytime: 05.31‐18.00 h, night‐time). Additional analyses performed to study pace at which algorithm adapts. Results Glycaemic control was kept 449 (mean = 152.6 ± 18.7 mg/dl, management indicator 7.0 0.4%, range 70.7 11.0%, below 70 mg/dl 2.3 2.3%). Albeit some metrics differed ( p < .0001 for all), absolute differences very small considered clinically irrelevant. During Ramadan, there no increased risk hypoglycaemia daytime (time 2.4%), highest (80.0 10.7%, night: 60.4 15.3%), while above 180 night‐time (37.3 16.3%, day: 17.7 10.7%). The adapted immediately upon lifestyle change. Conclusion is effective, safe fast adapting substantial changes that occur people with type 1 diabetes

Language: Английский

---